Filing Details

Accession Number:
0001578563-23-000073
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-08-22 18:20:27
Reporting Period:
2023-08-18
Accepted Time:
2023-08-22 18:20:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1665988 Bioventus Inc. BVS () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1432665 Iii P Anthony Bihl 4721 Emperor Boulevard, Suite 100
Durham NC 27703
Interim Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2023-08-18 13,290 $4.14 138,290 No 4 P Direct
Class A Common Stock Acquisiton 2023-08-18 26,595 $4.14 26,595 No 4 P Indirect By Spouse's Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Indirect By Spouse's Trust
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $3.89 to $4.405, inclusive. Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
  2. Reflects shares directly held by The Irene A. Bihl Revocable Trust of which the Reporting Person and his spouse are trustees and among the beneficiaries. The Reporting Person disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.